<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Saturday Evening Post &#187; restless leg syndrome</title>
	<atom:link href="http://www.saturdayeveningpost.com/topics/restless-leg-syndrome/feed" rel="self" type="application/rss+xml" />
	<link>http://www.saturdayeveningpost.com</link>
	<description>Home of The Saturday Evening Post</description>
	<lastBuildDate>Sat, 18 May 2013 12:00:17 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.5</generator>
		<item>
		<title>Restless Legs Syndrome: Drug Update</title>
		<link>http://www.saturdayeveningpost.com/2009/10/22/health-and-family/medical-mailbox/restless-legs-syndrome-drug-update.html?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=restless-legs-syndrome-drug-update</link>
		<comments>http://www.saturdayeveningpost.com/2009/10/22/health-and-family/medical-mailbox/restless-legs-syndrome-drug-update.html#comments</comments>
		<pubDate>Thu, 22 Oct 2009 05:01:53 +0000</pubDate>
		<dc:creator>Post Editors</dc:creator>
				<category><![CDATA[Medical Mailbox]]></category>
		<category><![CDATA[medical study]]></category>
		<category><![CDATA[restless leg syndrome]]></category>

		<guid isPermaLink="false">http://www.saturdayeveningpost.com/?p=12031</guid>
		<description><![CDATA[<p>In a preliminary study of people with restless legs syndrome (RLS), those taking the prescription drug pregabalin had fewer symptoms and spent more time in deep sleep than those given an inactive pill. The promising findings were presented at the American Academy of Neurology’s annual meeting. RLS affects up to one in 10 people. Pregabalin [...]</p><p><a href="http://www.saturdayeveningpost.com/2009/10/22/health-and-family/medical-mailbox/restless-legs-syndrome-drug-update.html">Restless Legs Syndrome: Drug Update</a>

<a href="http://www.saturdayeveningpost.com">The Saturday Evening Post</a></p>]]></description>
				<content:encoded><![CDATA[<p>In a preliminary study of people with restless legs syndrome (RLS), those taking the prescription drug pregabalin had fewer symptoms and spent more time in deep sleep than those given an inactive pill. The promising findings were presented at the American Academy of Neurology’s annual meeting. RLS affects up to one in 10 people. Pregabalin (brand name: Lyrica) is already FDA approved for treating nerve pain, seizures, and anxiety.</p>
<p><a href="http://www.saturdayeveningpost.com/2009/10/22/health-and-family/medical-mailbox/restless-legs-syndrome-drug-update.html">Restless Legs Syndrome: Drug Update</a>

<a href="http://www.saturdayeveningpost.com">The Saturday Evening Post</a></p>]]></content:encoded>
			<wfw:commentRss>http://www.saturdayeveningpost.com/2009/10/22/health-and-family/medical-mailbox/restless-legs-syndrome-drug-update.html/feed</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
	</channel>
</rss>
